Wangsu Science & Technology (300017) Fundamentals 2026 — P/E 49.5x, Revenue Analysis | SniperIQ
Wangsu Science & Technology (300017) is a CN-listed Technology company in Software - Infrastructure with a market capitalization of ¥36.7B, trading at ¥14.70 on the SHZ. This SniperIQ fundamentals page covers Wangsu Science & Technology's valuation (P/E 49.5x, P/B 3.4x), profitability (net margin 16.0%), revenue (¥4.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Wangsu Science & Technology's market cap?
Wangsu Science & Technology (300017) has a market capitalization of approximately ¥36.7B, trading at ¥14.70 on the SHZ. Market cap moves with the live share price.
What is Wangsu Science & Technology's P/E ratio?
Wangsu Science & Technology's trailing twelve-month P/E ratio is 49.5x, with a price-to-book (P/B) of 3.4x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
How profitable is Wangsu Science & Technology?
Wangsu Science & Technology runs a net profit margin of 16.0%, a gross margin of 37.2%, and an operating margin of 13.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Wangsu Science & Technology generate?
Wangsu Science & Technology reported revenue of ¥4.7B for fiscal year 2025, with net income of ¥800M and earnings per share (EPS) of 0.33. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Wangsu Science & Technology pay a dividend?
Wangsu Science & Technology offers a trailing dividend yield of about 1.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Wangsu Science & Technology financially healthy?
Wangsu Science & Technology carries a debt-to-equity ratio of 0.03x and a current ratio of 6.42x, with a market beta of 0.60. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Wangsu Science & Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Wangsu Science & Technology (300017) the key facts are: market cap ¥36.7B, P/E 49.5x, revenue ¥4.7B, 52-week range 9.66-24.1. Weigh valuation, profitability, growth, and balance-sheet strength against Technology peers and form your own view.
Track Wangsu Science & Technology's full fundamentals live
Get Wangsu Science & Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.